The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Interdisciplinary Collaboration at Wash U Advances Understanding of Immunology, Rheumatology

Interdisciplinary Collaboration at Wash U Advances Understanding of Immunology, Rheumatology

October 14, 2015 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Yokoyama

Dr. Yokoyama

emphasis on immunology, says Dr. Atkinson. There was “fortuitous overlap” with the Dermatology Department and skin biologists working on proteases, and with the pathology and the immunology programs. (Note: The latter two programs are now combined as the Department of Pathology and Immunology.) By the mid-1970s, when Dr. Atkinson came to St. Louis after his residency at Massachusetts General Hospital and post-doctoral work on the complement system at the NIH, “It became clear that immunology was going to dominate in rheumatology,” he says. Dr. Atkinson was given an HHMI investigator position and appointed director of the division in 1976.

You Might Also Like
  • Advances in Precision Immunology Require Precision Controls to Further Research
  • University of Alabama at Birmingham’s Division of Clinical Immunology & Rheumatology Recognized for Excellence
  • The ARHP Promotes Interdisciplinary Approach to Rheumatology Patient Care
Explore This Issue
October 2015
Also By This Author
  • The Evolution of Glucocorticoids

Challenging Scientific Dogma

“There are many different strategies to advance knowledge in rheumatology and the rheumatic diseases,” notes Wayne M. Yokoyama, MD, professor of medicine, and of pathology and immunology, Sam J. Levin and Andrey Loew Levin Chair for Research on Arthritis, and investigator, Howard Hughes Medical Institute. He was recruited to Wash U’s School of Medicine in 1995 to head the division in the Department of Medicine. Dr. Atkinson was chair of the Department of Medicine at that time. Dr. Yokoyama saw the move as “a great opportunity to join an institution that already had a strong basic immunology research community.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Yokoyama leads one of eight substantial research laboratories in the division and directs the Rheumatic Diseases Core Center, which is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). He is also a member of the National Academy of Sciences and the National Academy of Medicine (formerly the Institute of Medicine). Like Dr. Atkinson, Dr. Yokoyama is a recipient of the Lee C. Howley Prize for Research in Arthritis. He is prominently noted for his work on Ly49 receptors on natural killer (NK) cells, and the discovery of their intrinsic involvement in recognition of MHC Class I molecules, which “turn off” the NK cell, one of the first examples of inhibitory receptors on immune cells. That work was first begun relative to advancing the immune system understanding in cancer and led to breakthroughs in the immunologic bases of rheumatic and other autoimmune conditions.

“You don’t know where the advance will come from, or whether your work will have a bigger impact on a different disease, so having a broad perspective is useful,”
Dr. Yokoyama says. He also says his own post-doctoral and faculty mentors, such as Robert Ashman, MD, at the University of Iowa, Ethan Shevach, MD, at the NIH and Ira M. Goldstein, MD, at UCSF (who was also the first president of the newly renamed ACR), taught him “to do outstanding work and follow the data.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Professional Topics, Systemic Inflammatory Syndromes Tagged With: CHIKV, clinical trial, contracted chikungunya virus, Immunology, outcome, Research, rheumatologyIssue: October 2015

You Might Also Like:
  • Advances in Precision Immunology Require Precision Controls to Further Research
  • University of Alabama at Birmingham’s Division of Clinical Immunology & Rheumatology Recognized for Excellence
  • The ARHP Promotes Interdisciplinary Approach to Rheumatology Patient Care
  • Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)